Located in Raleigh, North Carolina, Veranex is an emerging medtech innovation services leader formed in 2020 by Summit Partners, a Boston-based growth fund, to address the need to support MedTech companies from conceptualization through commercialization. Veranex is structured around five areas of expertise: (i) product design and engineering, (ii) regulatory affairs & quality management, (iii) preclinical evaluation, (iv) clinical evaluation and data analysis, (iv) commercial and market access strategy.

As part of this investment, Lauxera is serving as Summit’s European partner focused on expanding Veranex’s service offering for MedTech start-ups looking to accelerate the development of their medical devices. In a global regulatory environment that is increasingly restrictive and complex, Veranex’s model enables the implementation of a coherent market access strategy that takes into account the risks and constraints at each stage of medical device development to accelerate market access while streamlining development costs.

Company : Veranex

Investment type :
Growth Buy-out

Investment date :
May 2022

Location : USA

Website :

Youtube : Youtube page

+ Clients served in medical device, diagnostics, life sciences, and digital health
+ Team members in product development and commercialization
+ Product development programs, regulatory submissions, and commercial launches in MedTech
“Europe is home to a vast ecosystem of innovative medical technology companies that can benefit from the wide-ranging services and capabilities Veranex delivers. This investment is an opportunity for Lauxera to participate in the organic and inorganic growth of the group while strengthening its toolbox for European medical technology companies to transform them into global champions of their category.”

Samuel Levy, Founding Partner at Lauxera